8
Views
4
CrossRef citations to date
0
Altmetric
Original

Early diagnosis of acute myocardial infarction. A comparison between chemical predictors

, , , &
Pages 633-639 | Received 26 Jan 1989, Accepted 30 Mar 1989, Published online: 29 Mar 2011

References

  • Sylvén C, Bendz R. Myoglobin, creatinekinase and its iso-enzyme MB in serum after acute myocardial infarction. Eur J Cardiol 1978; 8: 4–5
  • Nørregaard-Hansen K, Hyltoft Petersen P, Hangaard J, Simonsen E E, Rasmussen O, Hørder M. Early observations of S-myoglobin in the diagnosis of acute myocardial infarction. The influence of discrimination limit, analytical quality, patient's sex and prevalence of disease. Scand J Clin Lab Invest 1986; 46: 361–9
  • Scandinavian Committee on Enzymes (SCE). Recommended method for the determination of creatine kinase in blood, modified by inclusion of EDTA. Scand J Clin Lab Invest 1979; 39: 1–5
  • Gerhardt W, Waldenstrom J. Creatine kinase B subunit activity in serum after immuno-inhibition of M subunit activity. Clin Chem 1979; 25: 1274–80
  • Conover W J. Practical nonparametric statistics. Wiley & Sons, New York 1980; 133-ff
  • Galen R, Gambino S. Beyond normality. Wiley & Sons, New York 1975
  • Lee T H, Ronson G W, Weisberg M C, et al. Sensitivity of Routine Clinical Criteria for Diagnosing Myocardial Information Within 24 hours of Hospitalization. Am Int Med 1987; 106: 181–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.